Psychosocial factors and cognition in amyotrophic lateral sclerosis

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

Volumn 4, Issue 4, 2003, Pages 217-224

  Grossman, Alison ^a   Bradley, Walter ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

ALS; Neuropsychological impairment; Psychosocial factors

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; DYNACTIN;

AMYOTROPHIC LATERAL SCLEROSIS; AUTOSOMAL RECESSIVE INHERITANCE; BRAIN BLOOD FLOW; BRAIN FUNCTION; BRAIN REGION; COGNITION; COGNITIVE DEFECT; COPING BEHAVIOR; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; EMOTIONAL STRESS; EXPECTATION; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HELPLESSNESS; HEREDITY; HUMAN; LIFE EVENT; MEMORY CONSOLIDATION; MOOD; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PATHOGENESIS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PERSONALITY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; RELAXATION TRAINING; RELIGION; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOCIAL PSYCHOLOGY; SUPPORT GROUP; SYMPTOM;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AMYOTROPHIC LATERAL SCLEROSIS; CHRONIC DISEASE; COGNITION; COGNITION DISORDERS; CORONARY DISEASE; DIAGNOSTIC IMAGING; HUMANS; PERSONALITY; PSYCHOLOGY;

EID: 0242391706     PISSN: 14660822     EISSN: None     Source Type: Journal    
DOI: 10.1080/14660820310005554     Document Type: Review

References (121)

1. McDonald E, Hillel A, Wiedenfeld S. Evaluation of the psychological status of ventilatory-supported patients with ALS/MND. Palliative Medicine 1996; 10(1): 35-41.
2. Gelinas DF, O'Connor P, Miller RG. Quality of life for ventilator-dependent ALS patients and their caregivers. J Neurol Sci 1998; 160 (suppl 1): S134-136.
3. Ganzini L, Johnston WS, Hoffman WF. Correlates of suffering in amyotrophic lateral sclerosis. Neurology 1999; 52(7): 1434-1440.
4. Ross M, Kasarskis E, McCulloch J et al. Depression in ALS. Proceedings of the 10th International Symposium on ALS/MND, Vancouver, 8-10 Nov 1999; 67-68.
5. Robbins RA, Simmons Z, Bremer BA et al. Quality of life in ALS is maintained as physical function declines. Neurology 2001; 56(4): 442-444.
6. Simmons Z, Bremer BA, Robbins RA et al. Quality of life in ALS depends on factors other than strength and physical functions. Neurology 2000; 55(3): 388-392.
7. Ringel SP, Murphy JE, Alderson MK et al. The natural history of amyotrophic lateral sclerosis. Neurology 1993; 42: 1316-1322.
8. Tandan R, Bradley WG. Amyotrophic lateral sclerosis, I: clinical features, pathology, and ethical issues in management. Ann Neurol 1985; 18: 271-280.
9. McDonald E, Wiedenfeld SA, Hillel A et al. Survival in amyotrophic lateral sclerosis: the role of psychological factors. Archives of Neurology 1994; 51: 17-23.
10. Rosen DR, Siddique T, Patterson D et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62.
11. Brown RH Jr. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 1995; 80: 687-692.
12. Brown RH Jr. Amyotrophic lateral sclerosis: insights from genetics. Archives of Neurology 1997; 54: 1246-1250.
13. Hadano S, Hand CK, Dsuga H. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nature Genetics 2001; 29: 166-173.
14. Puls I, Jonnakuty C, Lamonte BH et al. Mutant dynactin in motor neuron disease. Nature Genetics 2003; 33(4): 455-456.
15. Shaw PJ. Genetic inroads in familial ALS. Nature Genetics 2001; 29: 103-104.
16. Yang Y, Hentati A, Deng HX et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nature Genetics 2001; 29: 160-165.
17. Stein MB, Jang KL, Livesley WJ. Heritability of social anxiety-related concerns and personality characteristics: a twin study. Journal of Nervous and Mental Disorders 2002; 190(4): 219-224.
18. Tandon K, McGuffin P. The genetic basis for psychiatric illness in man. European Journal of Neuroscience 2002; 16(3): 403-407.
19. Veldink JH, van den Berg LH, Cobben JM et al. Homozygous deletion of the survival motor neuron 2 gene is a prognostic factor in sporadic ALS. Neurology 2001; 56(6): 749-752.
20. Bradley WG, Good P, Rasool CG, Adelman LS. Morphometric and biochemical studies of peripheral nerves in amyotrophic lateral sclerosis. Ann Neurol 1983; 14(3): 267-277.
21. Abe K. Cognitive function in amyotrophic lateral sclerosis. ALS and Other Motor Neuron Disorders 2001; 1: 343-347.
22. Wilson CM, Grace GM, Munoz DC et al. Cognitive impairment in sporadic ALS: a pathologic continuum underlying a multi-system disorder. Neurology 2001; 57: 651-657.
23. Abe K, Fujimura H, Toyooka K et al. Single-photon emission computed tomographic investigation of patients with motor neuron disease. Neurology 1993; 43: 1569-1573.
24. Abrahams S, Leigh P, Harvey A et al. Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis. Neuropsychologia 2000; 38(6): 734-737.
25. Moretti R, Torre P, Antonello R et al. Complex cognitive disruption in motor neuron disease. Dementia and Geriatric Cognitive Disorders 2002; 14(3): 141-150.
26. Abrahams S, Goldstein LH, Al-Chalabi A et al. Relationship between cognitive dysfunction and pseudobulbar palsy in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry 1997; 62: 464-472.
27. Strong MJ, Grace GM, Orange JB et al. A prospective study of cognitive impairment in ALS. Neurology 1999; 53: 1665-1670.
28. Ludolph AC, Langen KJ, Regard M et al. Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study. Acta Neurol Scand 1992; 85(2): 81-89.
29. Abrahams S, Leigh PN, Kew JJ et al. A positron emission tomography study of frontal lobe function (verbal fluency) in amyotrophic lateral sclerosis. J Neurol Sci 1995; 129 (suppl): 44-46.
30. Abrahams S, Goldstein LH, Kew JJ et al. Frontal lobe dysfunction in amyotrophic lateral sclerosis: A PET study. Brain 1996; 119: 2105-2120.
31. Frank B, Haas J, Heinze HJ et al. T.F. Relation of neuropsychological and magnetic resonance findings in amyotrophic lateral sclerosis: evidence for subgroups. Clinics of Neurology and Neurosurgery 1997; 99(2): 79-86.
32. Abe K, Fujimura H, Toyooka K et al. Cognitive function in amyotrophic lateral sclerosis. J Neurol Sci 1997; 14: 95-100.
33. Shiozawa Z, Shindo K, Ohta E et al. A concise overview of recent breakthroughs in imaging of ALS. ALS and Other Motor Neuron Disorders 2000; (suppl 2): S3-6.
34. Cohen S. Psychosocial models of the role of social support in the etiology of physical disease. Health Psychology 1988; 7: 269-297.
35. Cohen S, Wills TH. Stress, social support, and the buffering hypothesis. Psychological Bulletin 1985; 98: 310-357.
36. Brown GK, Nicassio PM, Wallston KW. Pain coping strategies and depression in rheumatoid arthritis. Journal of Consulting and Clinical Psychology 1989; 57: 652-657.
37. Ward SE, Leventhal H, Love R. Repression revisited: tactics used in coping with a severe health threat. Personality and Social Psychology Bulletin 1988; 14(4): 735-746.
38. Herbert T, Cohen S. Depression and immunity: a meta-analytic review. Psychological Bulletin 1993; 113: 472-486.
39. Byrnes D, Antoni MH, Goodkin K et al. Stressful events, pessimism, natural killer cell cytotoxicity, and cytotoxic/suppressor T cells in HIV and black women at risk of cervical cancer. Psychosomatic Medicine 1998; 60: 714-722.
40. Goodkin K, Antoni MH, Blaney PH. Stress and hopelessness in the promotion of cervical intraepithelial neoplasia to invasive squamous cell carcinoma of the cervix. Journal of Psychosomatic Research 1986; 30: 67-76.
41. Scheier MF, Bridges MW. Person variables and health: personality predispositions and acute psychological states as shared determinants for disease. Psychosomatic Medicine 1995; 57: 255-268.
42. Greer S, Morris T. Psychological attributes of women who develop breast cancer: a controlled study. Journal of Psychosomatic Research 1975; 19: 147-153.
43. Lavery JF, Clarke VA. Causal attributions, coping strategies, and adjustment to breast cancer. Cancer Nursing 1996; 19(1): 20-28.
44. Drugan RC, Basile AS, Ha JH et al. Analysis of the importance of controllable versus uncontrollable stress on subsequent behavioral and physiological functioning. Brain Res Protoc 1997; 2(1): 69-74.
45. Antoni MH, August S, LaPerriere A et al. Psychological and neuroendocrine measures related to functional immune changes in anticipation of HIV-1 serostatus notification. Psychosomatic Medicine 1990; 52(5): 496-510.
46. Ironson G, Wynings C, Schneiderman N et al. Post-traumatic stress symptoms, intrusive thoughts, loss, and immune function after Hurricane Andrew. Psychosomatic Medicine 1997; 59(2): 128-141.
47. Schneiderman N. Behavioral medicine and the management of HIV/AlDS. International Journal of Behavioral Medicine 1999; 6(1): 3-12.
48. Lesserman J, Jackson ED, Petitto JM et al. Progression to AIDS: the effects of stress, depressive symptoms, and social support. Psychosomatic Medicine 1999; 61: 397-406.
49. Page-Shafer K, Delorenze GN, Satariano WA, Winkelstein W Jr. Comorbidity and survival in HIV-infected men in the San Francisco Men's Health Survey. Annals of Epidemiology 1996; 6(5): 420-430.
50. Mayne TJ, Vittinghoff E, Chesney MA et al. Depressive effect and survival among gay and bisexual men infected with HIV. Archives of Internal Medicine 1996; 156(19): 2233-2238.
51. Patterson TL, Shaw WS, Semple SJ et al. Relationship of psychosocial factors to HIV disease progression. Annals of Behavioral Medicine 1996; 18: 30-39.
52. Coates TJ, McKusick L, Kuno R, Stites DP. Stress reduction for men with HIV. Advances 1989; 6(3): 7-8.
53. Mulder CL, Emmelkamp PMG, Antoni MH et al. Cognitive-behavioral and experiential group psychotherapy for HIV-infected homosexual men: a comparative study. Psychosomatic Medicine 1994; 56: 423-431.
54. Goodkin K, Blaney NT, Tuttle RS, Nelson RH. Bereavement and HIV infection. International Review of Psychiatry 1996; 8(2-3): 201-216.
55. Antoni MH, Baggett L, Ironson G et al. Cognitive-behavioral stress management intervention buffers distress responses and immunologic changes following notification of HIV-1 seropositivity. Journal of Consulting and Clinical Psychology 1991; 59: 906-915.
56. Esterling B, Antoni M, Schneiderman N et al. Psychosocial modulation of antibody to Epstein-Barr viral capsid antigen and human herpes virus - type 6 in HIV-1 infected and at-risk gay men. Psychosomatic Medicine 1992; 54: 354-371.
57. Ironson G, Friedman A, Klimas N et al. Distress, denial and low adherence to behavioral interventions predict faster disease progression in gay men infected with human immunodeficiency virus. International Journal of Behavioral Medicine 1994; 1: 90-105.
58. Lutgendorf SK, Antoni MH, Ironson G et al. Cognitive behavioral stress management decreases dysphoric mood and Herpes Simplex Virus-Type 2 antibody titers in symptomatic HIV-seropositive gay men. Journal of Consulting and Clinical Psychology 1997; 65: 31-43.
59. Lutgendorf SK, Antoni MH, Ironson G et al. Changes in cognitive coping skills and social support during cognitive behavioral stress management intervention and distress outcomes in symptomatic human immunodeficiency virus (HIV)-seropositive gay men. Psychosomatic Medicine 1998; 60: 204-214.
60. Cruess S, Antoni M, Cruess D et al. Reductions in herpes simplex virus type 2 antibody titers after cognitive behavioral stress management and relationships with neuroendocrine function, relaxation skills, and social support in HIV-positive men. Psychosomatic Medicine 2000; 62(6): 828-837.
61. Antoni MH, Cruess D, Cruess S et al. Cognitive-behavioral stress management intervention effects on anxiety, 24-hour urinary norepinephrine output, and T-cytotoxic/suppressor cells over time among symptomatic HIV-infected gay men. Journal of Consulting and Clinical Psychology 2000; 68(1): 31-45.
62. Antoni MH, Schneiderman N, Fletcher MA et al. Psychoneuroimmunology and HIV-1. Journal of Consulting and Clinical Psychology 1990; 58: 38-49.
63. Rozanski A, Blumenthal JA, Kaplan J, Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation 1999; 99(16): 2192-2217.
64. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. American Journal of Cardiology 1999; 83(9B): 25F-29F.
65. Suarez EC, Williams RB, Harlan ES et al. Hostility-related differences in urinary excretion rates of catecholamines. Paper presented at annual meeting of Society for Psychophysiological Research: Chicago: October 1991.
66. Shiller AD, Suarez EC, Kuhn CM et al. Hostility is associated with lymphocyte beta-2 adrenergic receptor/adenylate cyclase activity. Paper presented at the annual meeting of the American Psychosomatic Society. Boston, MA: April 1994.
67. Dusseldorp E, vanElderen T, Maes S et al. A meta-analysis of psychoeducational programs for coronary heart disease patients. Health Psychology 1999; 18(5): 506-519.
68. Linden W, Stossel C, Maurice J. Psychosocial interventions for patients with coronary artery disease: a meta-analysis. Archives of Internal Medicine 1996; 156(7): 745-752.
69. Friedman M, Thoresen C, Gill JJ et al. Alteration of Type A behavior and its effect on cardiac recurrences in postmyocardial infarction patients: summary results of the recurrent coronary prevention project. American Heart Journal 1986; 112(4): 653-655.
70. Friedman M, Powell L, Thoresen CE et al. Effect of discontinuance of Type A behavioral counseling on type A behavior and cardiac recurrence rate of post myocardial infarction patients. American Heart Journal 1987; 114: 483-490.
71. Ornish D, Brown SE, Scherwitz LW et al. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial. Lancet 1990; 336: 129-133.
72. Johnston M, Earll L, Giles M et al. Mood as a predictor of disability and survival in patients diagnosed with ALS/MND. British Journal of Health Psychology 1999; 4 (Part 2): 127-136.
73. Temoshok L. Personality, coping style, emotion and cancer: towards an integrative model. Cancer Survival 1987; 6: 545-567.
74. Antoni MH, Goodkin K. Host moderator variables in the promotion of cervical neoplasia; I: personality facets. Journal of Psychosomatic Research 1988; 32: 327-338.
75. Bernhard J, Ganz PA. Psychosocial issues in lung cancer patients (part 1). Chest 1991; 99: 216-223.
76. Friedman M, Rosenman R. Association of a specific overt behavior pattern with blood and cardiovascular findings. JAMA 1959; 169: 1286-1296.
77. Dembroski TM, MacDougall JM, Costa Jr. PT et al. Components of hostility as predictors of sudden death and myocardial infarction in the multiple risk factor intervention trial. Psychosomatic Medicine 1989; 51: 514-522.
78. Appels A. Personality factors and coronary heart disease. In: Orth-Gomer K, Schneiderman N. (eds.) Behavioral medicine approaches to cardiovascular disease prevention. New Jersey: Lawrence Erlbaum Associates, 1996: 149-160.
79. Hecker MHL, Chesney MA, Black GW et al. Coronary-prone behaviors in the Western collaborative group study. Psychosomatic Medicine 1988; 50: 153-164.
80. Suarez EC, Williams RB, Kuhn CM et al. Biobehavioral basis of coronary-prone behavior in middle-age men. Part II. Serum cholesterol, the type A behavior pattern, and hostility as interactive modulators of physiological reactivity. Psychosomatic Medicine 1991; 53: 528-537.
81. Smith TW. Hostility and health: current status of a psychosomatic hypothesis. Health Psychology 1992; 11: 139-150.
82. Ketterer MW, Fitzgerald F, Thayer B et al. Psychosocial and traditional risk factors in early ischaemic heart disease: cross-sectional correlates. Journal of Cardiovascular Risk 2000; 7(6): 409-413.
83. Kop J. Chronic and acute psychological risk factors for clinical manifestations of coronary artery disease. Psychosomatic Medicine 1999; 61: 476-487.
84. Siegler IC, Peterson BL, Barefoot JC et al. Hostility in late adolescence predicts coronary risk factors at mid-life. American Journal of Epidemiology 1992; 136: 146-156.
85. Scherwitz LW, Perkins LL, Chesney MA et al. Hostility and health behaviors in young adults: the CARDIA study. Coronary artery risk development in young adults study. American Journal of Epidemiology 1992; 136: 136-145.
86. Fukudo S, Lane JD, Anderson NB et al. Accentuated vagal antagonism of beta-adrenergic effects on ventricular repolarization: evidence of weaker antagonism in hostile men. Circulation 1992; 85: 2045-2053.
87. Williams RB. Coronary-prone behaviors, hostility, and cardiovascular health: implications for behavioral and pharmacological interventions. In: Orth-Gomer K, Schneiderman N. (eds.) Behavioral medicine approaches to cardiovascular disease prevention. New Jersey: Lawrence Erlbaum Associates, 1996: 161-168.
88. Menza M. The personality associated with Parkinson's disease. Current Psychiatry Reports 2000; 2(5): 421-426.
89. Camp CD. Paralysis agitans, multiple sclerosis and their treatment. In: White WA, Jelliffe SE, Kimpton H. (eds.) Modern Treatment of Nervous and Mental Disease. Philadelphia: 1913: 651-667.
90. Jelliffe SE. The Parkinsonian body posture: some considerations on unconscious hostility. Psychoanalyst Review 1940; 27: 467-479.
91. Sands I. The type of personality susceptible to Parkinson's disease. Journal of Mt. Sinai Hospital 1942; 9: 792-794.
92. Mitscherlich M. The psychic state of patients suffering from Parkinsonism. Advances in Psychosomatic Medicine 1960; 1: 317-324.
93. Poewe W, Gerstenbrand F, Ransmayr G, Plorer S. Premorbid personality of Parkinson patients. Journal of Neural Transmission 1983; 19 (suppl): 215-224.
94. Ward CD, Duvoisin RC, Ince SE et al. Parkinson's disease in twins. In: Hassler RG, Christ JF (eds.) Advances in Neurology. New York: Raven Press: 1984.
95. Strauss M, Pasupathi M. Primary caregivers' descriptions of Alzheimer patients' personality traits: temporal stability and sensitivity to change. Alzheimer's disease and Associated Disorders 1994; 8(3): 166-176.
96. Strauss M, Lee M, DiFilippo J. Premorbid personality and behavioral symptoms in Alzheimer's disease: some cautions. Arch Neurol 1997; 54(3): 257-259.
97. Dawson DV, Welsh-Bohmer K, Siegler. Premorbid personality predicts level of rated personality change in patients with Alzheimer's disease. Alzheimer Disease and Associated Disorders 2000; 14(1): 11-19.
98. Bradley WG, Good P, Rasool CG, Adelman LS. Morphometric and biochemical studies of peripheral nerves in amyotrophic lateral sclerosis. Annals of Neurology 1983; 14(3): 267-277.
99. Lowe J. New pathological findings in amyotrophic lateral sclerosis. J Neurol Sci 1994; 124: 38-51.
100. Jackson M, Lennox G, Lowe J. Motor neuron disease-inclusion dementia. Neurodegeneration 1996; 5: 339-350.
101. Swash M. How many ALS syndromes? Neurology 2002; 59: 967.
102. Kew JJM, Goldstein LH, Leigh PN et al. The relationship between abnormalities of cognitive function and cerebral activation in amyotrophic lateral sclerosis: a neuropsychological and positron emission tomography study. Brain 1993; 116: 1399-1423.
103. Ringholz GM, Mosnik DM, Roebuck TM, McMurray PJ. Rethinking the cognitive deficits associated with amyotrophic lateral sclerosis: incidence and subtypes. Ann Neurol 2002, (suppl 1).
104. Massman PJ, Sims J, Cook N et al. Prevalence and correlates of neuropsychological deficits in amyotrophic lateral sclerosis. Neurosurgery, and Psychiatry 1996; 61: 450-455.
105. Kew JJM, Leigh PN. Unusual forms of dementia. In: Burns A, Levy, R. (eds.) Dementia. London: Chapman & Hall, 1994 : 1: 789-811.
106. Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 2002; 59: 1077-1079.
107. Neary D, Snowden JS, Mann DMA. Cognitive change in motor neurone disease/amyotrophic lateral sclerosis (MND/ALS). J Neurol Sci 2000; 180: 15-20.
108. Chow T, Miller B, Hayashi V, Geschwind D. Inheritance of frontotemporal dementia. Arch Neurol 1999; 56: 817-822.
109. Snowden J, Neary D, Mann DMA. Frontotemporal lobar degeneration: frontotemporal dementia, progressive aphasia, semantic dementia. New York: Churchill Livingstone: 1996.
110. Mitsuyama Y. Dementia with motor neurone disease. Neuropathy 2000; 20 (suppl): S79-81.
111. Foster L, Withelmsen K, Sima A et al. Frontotemporal dementia and Parkinsonism linked to chromosome 17: a consensus conference. Ann Neurol 1997; 41: 706-715.
112. Kuzuhara S, Kokubo Y, Sasaki et al. Familial amyotrophic lateral sclerosis and Parkinsonism-dementia complex of the Kii peninsula of Japan: clinical and neuropathological study and tau analysis. Ann Neurol 2001; 49(4): 501-511.
113. Poorkaj P, Tsuang D, Wijsman E et al. Tau as a susceptibility gene for amyotrophic lateral sclerosis-Parkinsonism dementia complex of Guam. Arch Neurol 2001; 58(11): 1871-1878.
114. Hosler BA, Siddique T, Sapp PC et al. Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. JAMA 2000; 284(13): 1664-1669.
115. Doran M, Xuareb J, Hodges JR. Rapidly progressive aphasia with bulbar motor neurone disease: a clinical and neuropsychological study. Behavioral Neurology 1995; 8: 169-180.
116. Talbot P, Goulding P, Lloyd JJ et al. Inter-relation between "classic" motor neurone disease and frontotemporal dementia: neuropsychological and single photon emission computed tomography study. Journal of Neurology, Neurosurgery, and Psychiatry 1995; 58: 541-547.
117. Gallassi R, Montagna P, Ciardulli C et al. Cognitive impairments in motor neurone disease. Acta Neurol Scand 1985; 71: 480-484.
118. Iwasaki Y, Kinoshita M, Ikeda K et al. Cognitive impairment in amyotrophic lateral sclerosis and its relation to motor disabilities. Acta Neurol Scand 1990; 81: 141-143.
119. David AS, Gillham RA. Neuropsychological study of motor neurone disease. Psychosomatics 1986; 27: 441-445.
120. Poloni M, Capitani E, Maggini L, Ceroni M. Neuropsychological measures in amyotrophic lateral sclerosis and their relationship with CT scan-assessed cerebral atrophy. Acta Neurol Scand 1986; 74: 257-260.
121. Newsom-Davis IC, Lyall RA, Leigh PN et al. The effect of non-invasive positive pressure ventilation (NIPPV) on cognitive function in amyotrophic lateral sclerosis (ALS): a prospective study. Journal of Neurology, Neurosurgery, and Psychiatry 2001; 71(4): 482-487.